Bridging Science and Industry: A Conversation with Alberto Schena of Knowledge Transfer UNIL CHUV
In 2024, the University of Lausanne licensed its technology into i-Seq Biotechnology, Inc., a company formed by VIC Tech to advance novel, broad-spectrum vaccines and therapeutics against infectious disease pathogens...

